According to the Global Cancer Observatory (GLOBOCAN), in 2022, India recorded 1.41 million new cancer cases, placing it third globally after China and the United States of America
Read MoredeSouza, a Silicon Valley tech veteran and former CEO of Illumina brings over 30 years of leadership experience in genomics, technology, and healthcare
Read MoreAdvances in precision medicine have led to the integration of targeted therapies and immunotherapy, offering promising outcomes for certain patients
Read MoreRenowned oncologists presented significant findings from recent studies and trials on targeted therapies, immunotherapy treatments like Pembrolizumab, cyclin inhibitor tablets, and new surgical procedures and radiation techniques
Read More